Edition:
United States

Healthcare Headlines

LPC: Bank lending undeterred by busted U.S. mergers

NEW YORK Banks losing fees from a string of mega-mergers scuttled by U.S. antitrust rulings are still eager to extend loans to investment-grade companies seeking big tie-ups, in the hope they will ultimately profit by winning business down the road.    

Advent raises bid in three-way tussle for Stada

FRANKFURT Buyout firm Advent International raised the stakes in the three-way bidding tussle for German drug company Stada Arzneimittel on Thursday with a 3.6 billion euro ($3.8 billion) takeover offer, giving management until Monday to respond.

Exane adds Imperial Brands and Glanbia to M&A targets list

LONDON Tobacco company Imperial Brands and nutritional ingredients maker Glanbia are attractive targets for Japanese companies looking to expand into international markets, Exane BNP Paribas analysts said in a note to clients.

Icahn buys Bristol-Myers shares, adding to activist pressure

Billionaire investor Carl Icahn has taken a stake in Bristol-Myers Squibb Co and sees the drugmaker as a possible takeover target, according to a report published on Tuesday that sent the company's shares from a loss to more than 2 percent higher.

« Previous Page Next Page »
Photo

U.S. appeals court will not put Trump travel ban case on hold

SAN FRANCISCO A federal appeals court on Monday rejected a U.S. Department of Justice request to place on hold an appeal over President Donald Trump's travel ban on people from seven majority-Muslim countries.